• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

California Backs Psychedelic Research for Veterans

LOS ANGELES – When Gov. Gavin Newsom signed Assembly Bill 113, he gave California the distinction of becoming the first state to fund psychedelic-assisted therapy research through an official budget appropriation. The legislation channels $4.7 ...

Fluent Offloads Pennsylvania Dispensaries

NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...

DEA Increases Psychedelics Production Quotas for 2026

WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...

Wyld Acquires Grön

SEATTLE – Wyld, a leading producer of THC-CBD-infused gummies and chocolates, announced its agreement to acquire Grön, a Portland-based maker of sugar-coated pearls and confections, in a move that unites two prominent players in the ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

California Allocates $30M in Cannabis Research Grants

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly $30 million to support 22 academic projects examining Cannabis's influence on public health, environmental practices, and the regulated market. The funding, drawn from taxes on ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Vireo Growth Acquires PharmaCann Colorado Assets

DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...

Subscribe To Our Newsletter

Go to Top